Author Topic: (Abst.) Refractory epilepsy following natalizumab-associated PML  (Read 58 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8244
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Refractory epilepsy following natalizumab-associated PML
« on: December 19, 2017, 02:43:17 pm »
From PubMed, December 19, 2017:

Quote
Mult Scler Relat Disord. 2017 Dec 13;20:1-2.

Refractory epilepsy following natalizumab associated PML

Abkur TM1, Kearney H2, Hennessy MJ2.

Author information
1
Department of Neurology, Galway University Hospital, Galway, Ireland. Electronic address: tarig1982@hotmail.com.
2
Department of Neurology, Galway University Hospital, Galway, Ireland.

Natalizumab treatment of multiple sclerosis (MS) is associated with a risk of developing progressive multifocal leukoencephalopathy (PML), a rare opportunistic viral demyelinating disease caused by reactivation of John Cunningham virus (JCV). Herein we report a case of a 40-year-old woman who developed refractory temporal lobe epilepsy one year after recovery from Natalizumab-induced PML. Localisation related epilepsy, which may be refractory in nature, as in this case report, is a potential chronic disabling complication of PML. Epilepsy in this context likely reflects grey matter involvement, which may then act as cortical epileptogenic zone.

https://www.ncbi.nlm.nih.gov/pubmed/29253743
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
56 Views
Last post November 10, 2017, 10:52:57 am
by agate
0 Replies
46 Views
Last post March 03, 2018, 02:19:02 pm
by agate
0 Replies
38 Views
Last post May 04, 2018, 02:21:14 pm
by agate
0 Replies
50 Views
Last post February 05, 2019, 08:23:32 pm
by agate
0 Replies
38 Views
Last post April 07, 2019, 03:55:02 pm
by agate